CLINICAL_TRIALS trial_result · 2018-04-25

Clinical Trial Update: An Open Label Extension Study in Participants With Rheumatoid Arthritis [Phase 2]

This is an open-label extension study update in rheumatoid arthritis (Phase 2) with completed status and results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2018-04-25